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The ability to identify potential neurotoxicants depends upon the characteristics of our test
instruments. The neurotoxic properties of lead, methylmercury, polychlorinated biphenyls, and
organic solvents would all have been detected at some dose level by tests in current use,
provided that the doses were high enough and administered at an appropriate time such as
during gestation. The adequacy of animal studies, particularly rodent studies, to predict intake
levels at which human health can be protected is disappointing, however. It is unlikely that the
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This paper on model compounds addresses
the lessons that may be extracted from the
intensive investigation over the last 15 years
or so ofselected agents (lead, methylmer-
cury) or classes ofagents (polychlorinated
biphenyls [PCBs], solvents) identified as
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potent neurotoxicants by environmental or
industrial exposure ofhuman populations.
Such recognition in each case prompted
extensive research in animal models
to characterize effects and to predict poten-
tial neurotoxic end points in humans.
Epidemiological investigation focused on
characterizing effects in the human popula-
tion and identifying no-effect levels. Much
of the research on the effects of lead,
methylmercury, and PCBs has focused on
identifying behavioral and other neurotoxic
effects produced as a result ofdevelopmen-
tal exposure, while most ofthe research on
solvents has focused on exposure in adults.
There are a number of questions that
may be asked regarding what we have
learned from these neurotoxic agents. How
was neurotoxicity identified in the human
population? How well are the effects char-
acterized in humans, and how confident are
we ofour estimates ofthe intake or body
burden necessary to produce effects? What
do we know about the nature ofeffects in
adults versus those in the developing
organism? How good are animal models in
identifying the neurotoxic potential ofthese
agents? How well do effects in animals pre-
dict effects in humans? And finally, how
well do the estimates ofsafe levels based on
animal models actually predict what we
know about intake necessary to produce
human neurotoxicity?
Characterization of Effects
Lead
The recognition oflead as a neurotoxicant
arose initially in the ancient world where
the classic signs oflead poisoning-colic,
constipation, pallor and palsy-were recog-
nized by both the Greeks and Romans.
This recognition reemerged in the 17th
century and was brought to public atten-
tion periodically thereafter. Occupational
exposure to lead still poses a threat to the
health ofworkers, resulting in peripheral
neuropathy and deficits in attention and
cognitive function (1,2). Early in the 20th
century, it was recognized that children
represent a particularly vulnerable popula-
tion, with exposure potentially resulting in
encephalopathy and death. Despite this
recognition, lead was used widely in paint
and other industrial products and added to
gasoline, ensuring worldwide and persis-
tent distribution. Over the next several
decades, physicians continued to report
untoward effects as a result oflead expo-
sure in children. As early as the 1940s there
was a recognition that permanent neuro-
logical damage could result from exposure
to lead at levels that had never produced
overt signs oftoxicity. In 1979, a landmark
study by Needleman and colleagues in
Boston (3) reported decreased intelligence
quotient (I) and an increased incidence
ofdistractibility and inattention in middle-
class children with no identifiable source of
lead exposure. The conclusion to be drawn
from this study was that environmental
sources oflead were producing intellectual
impairment in children at levels that had
come to be regarded as normal.
In the last decade and a half, there has
been intense research into the health effects
oflead in children and developing animals,
such that probably more is known about
the health effects of lead than any other
noncarcinogenic environmental contami-
nant (4-8). The result in the United States
has been that, over the last two decades, the
blood level oflead considered safe for chil-
dren has rapidly decreased to the present
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level of 10 jpg/dl. Prospective studies in
Boston, Cincinnati, Port Pirie, and New
Zealand, as well as a number ofcross-sec-
tional studies, have demonstrated deficits
in IQas a function ofincreased body bur-
den oflead after control for potential con-
founding variables. A 10 pg/dl increase in
blood lead level is associated with about a
3 point deficit in IQaccording to a recent
meta-analysis (7). These effects have been
documented from infancy through early-to-
middle school age; historic lead levels have
often been a better predictor ofdeficit than
concurrent blood lead levels. Assessment of
behavior by teachers or parents has revealed
short attention span, increased distractibil-
ity, hyperactivity, and problems in follow-
ing sequences ofdirections as a function of
increased blood lead levels. Not surpris-
ingly, deficits in school performance are
also associated with an increased body bur-
den oflead. Epidemiological studies in
children have revealed deficits on vigilance
tasks andincreased reaction time, which may
reflect increased distractibility and/or
decreased attention span. Lead-exposed chil-
dren also engage in perseverative behavior,
continuingtorespond ininappropriateways.
The early animal research in the 1970s
focused largely on the effects ofexposure to
high doses oflead on simple learning prob-
lems. Studies in which rats were prenatally
exposed generally revealed lead-induced
deficits, while postnatal or adult exposure
generally produced no impairment (9). As
behavioral methodology was refined, how-
ever, it became clear that the prenatal
period was not the only period sensitive to
lead-induced impairment. Lead research
using animal models over the last 15 years
has revealed lead-induced impairment at
increasingly lower doses and on a wide
range of behavioral tasks. Much of the
more sophisticated work in rodents was
performed at the University ofRochester
by Cory-Slechta and colleagues using a
postweaning exposure paradigm (8,10).
Extensive research has also been performed
in two species ofmacaque monkeys, the
rhesus and cynomolgus (crab-eating), in
three different laboratories (8). Exposure
was prenatal, postnatal, or lifetime in vari-
ous experiments. Robust deficits have been
observed in monkeys exposed only prena-
tally or only postnatally and tested years
after cessation ofexposure, as well as in
monkeys with low blood lead levels exposed
over a lifetime. Consistent effects have been
observed on complex tests oflearning and
memory. Analysis oferrorpatterns responsi-
ble for lead-induced deficits has consistendy
revealed increased distractibility, persevera-
tion, inability to inhibit inappropriate
responding, andinabilityto change response
strategy as hallmarks ofdevelopmental lead
exposure in both rats and monkeys.
An interesting parallel in methodologies
between the experimental and epidemiologi-
cal literature addressed the effect oflead
exposure on the ability to change response
strategies from an established pattern to a
newone. This issuewas assessed in monkeys
using a series ofdiscrimination reversal tasks
and in children using the Wisconsin Card
Sort Test. The test in monkeys required
them to learn asimplevisual discrimination;
once theylearned the task, the formerlycor-
rect stimulus became the incorrect one, and
vice versa (11,12). A series ofsuch reversals
was performed. Then the rules were
changed in a different way: the relevant
stimulus dimension changed from form (tri-
angle vs cross) to color (red vs green). The
triangle and cross were still superimposed
on the colors; however, each appeared on
the red or green in a balanced design. The
monkey was required to learn to ignore the
(formerly relevant) forms and to attend to
the colors. After a series ofreversals on this
task, the relevant stimulus dimension was
changed from color to form and the mon-
key was required to switch strategies again.
In the Wisconsin Card Sort Test, the 10-
year-old child was required to pick the card
that went with a set ofexamples presented
by the investigator (13). The relevant stim-
ulus class could be color, number, or suit.
The experimenter changed the relevant
stimulus dass at a number ofpoints during
the experiment. Thus, both ofthese tests
required thesubjecttochangean established
response strategy and to figure out that a
new rule was in effect. Both lead-exposed
children and monkeys were impaired in
their ability to do so: they stayed with an
oldstrategythatwas nolongeruseful.
Recent epidemiological studies suggest
that children with blood lead levels as low
as 10 jig/dl are impaired relative to chil-
dren with lower blood lead levels (8). A
recent meta-analysis concluded that there
was no evidence for a threshold for lead-
induced deficits down to a blood lead level
of 1 pg/dl (7). These data are consistent
with data from monkeys in which a group
with blood lead levels of 11 pg/dl were
impaired on a number oftasks compared
to controls with blood lead levels below 5
pg/dl (8). Behavioral impairment has been
observed in rats with blood lead levels of
20 pg/dl (14). A no-effect dose has not
been observed in either the monkey or rat
studies. It is probable that the very strong
evidence from both the experimental and
epidemiological studies concerning the dele-
terious effects oflead were necessary for the
decision ofthe Centers for Disease Control
and Prevention in the United States to set
the current action level for children at
10 ,ug/dl. Lead levels have decreased in
North America as a result ofthe removal of
lead from gasoline in the 1970s, although
leaded paint in old houses continues to pre-
sent a hazard. In many other countries, lead
is still allowed in gasoline and paint, and
average blood lead levels in children are
higherthan theyare inNorthAmerica.
Blood lead levels in children typically
peak at about 2 years ofage and decrease
thereafter. Ofcourse, exposure to additional
sources oflead may result in a temporary
increase in lead body burden at any time
during childhood. It is therefore important
to determine whether these peaks in blood
lead levels have lasting consequences. It
was known as early as the 1940s that overt
lead toxicity could produce permanent
behavioral sequelae in children (8). Data
from the modern prospective studies, in
which behavioral performance at 5 to 10
years of age often correlated best with
blood lead levels early in life, around the
age ofthe peak in blood lead levels, are
suggestive of long-lasting impairment,
although the continued exposure to lead
makes interpretation difficult. Experiments
in which monkeys were exposed either in
utero only or postnatally for a year or less
have demonstrated clear deficits on a num-
ber ofbehavioral tasks when monkeys were
adults (8). Thus, experimental research, in
which there is the opportunity to control
exposure conditions, was able to address an
important issue that cannot be addressed
directlyepidemiologically.
The animal literature has also provided
clarification to the epidemiological litera-
ture with regard to an issue that has proved
contentious: the control ofconfounding
variables in epidemiological studies. It is
well known that IQ is affected by many
variables: e.g., parental IQ, socioeconomic
status, maternal ingestion ofvarious drugs
during pregnancy (including tobacco and
alcohol), obstetric complications, and birth
weight. In many ofthe lead studies, some
ofthese variables, particularly socioeco-
nomic status and maternal IQ, were highly
correlated with children's blood lead levels.
In most studies, adjusting for various
potential confounders decreased the statis-
tical significance ofthe effect oflead. (This
was not always the case, however. In the
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prospective study in Boston, for example,
socioeconomic status was higher in chil-
dren with higher blood lead levels so that
lead effects were more significant after
covariate adjustment.) The argument has
been made that effects attributed to lead
were in fact due to some other unidentified
factor that also covaried with lead levels.
This assertion ignores the rather substantial
animal literature reporting lead-induced
deficits at roughly the same blood lead lev-
els as those reported in children. The results
from animal studies are not plagued by
such potential confounders; subjects are
randomly assigned to exposure groups, and
all variables except exposure to lead are kept
as constant as possible. The congruence of
effects thus provides reassurance that the
results ofthe epidemiological studies are
not misleading.
The recognition ofthe potential for a
profound effect on the population to be
produced by a small effect has been high-
lighted by the decision to expose millions
ofchildren to lead. Generally, the effect of
lead only accounts for a few percent ofthe
variance on measures of IQ since IQ is
influenced by many factors. It has been
argued that the effects oflead are therefore
unimportant. However, a 5 point decre-
ment in IQ, identified in many prospective
studies, will have a catastrophic effect on
the characteristics ofthe population. It will
result in a decrease in the number ofpeo-
ple with IQs above 130 by more than half
while concomitantly increasing those with
IQs below 70, resulting in substantial eco-
nomic and other consequences (15).
Methylmey
Methylmercury is known as one of the
most hazardous environmental pollutants,
largely due to endemic disasters such as
Minamata disease inJapan and methylmer-
cury poisoning in Iraq (16). In both
tragedies, infants exposed in utero were
severely affected, even though their moth-
ers may have had minimal symptoms of
methylmercury poisoning. Thus, the devel-
opmental toxicity ofmethylmercury had
become a focus ofboth human and animal
studies. Even today there are several popu-
lations that are exposed to methylmercury
-througir substantial fish consumption.
Effects of in utero exposure to methylmer-
cury in infants born to these populations
are currently being evaluated.
Minamata disease was first identified
among people living along Minamata Bay
in Kyushu, Japan. The source ofmethyl-
mercury was effluent from a chemical
company where mercury was used as a
catalyst. As a result ofbioconcentration in
the food chain, high concentrations of
methylmercury accumulated in fish and
shellfish. Abnormal gait, dysarthria, ataxia,
deafness, and constriction ofthe visual field
were the main symptoms. Cats living in the
villagers' homes showed signs of motor
impairment similar to those manifested in
humans. The early epidemiological investi-
gation concluded that an unidentified toxic
agent in fish and shellfish was responsible.
It took almost 3 years to identify the causal
agent by experimental pathology, clinical
study, and chemical analyses of environ-
mental samples. The report 3 years later
finally concluded that "organic mercury is
most suspected" (16).
Methylmercury easily crosses the pla-
centa, and the developing brain can be
severely affected by the compound. In the
Minamata tragedy, affected infants mani-
fested severe disease resembling cerebral
palsy. Mental retardation, cerebellar
ataxia, primitive reflex, dysarthria, seizure,
and pyramidal signs were also observed.
Because of the severity of signs in the
infants, the typical symptoms such as con-
striction of the visual field could not be
examined. The mothers ofthese children
had seemed healthy at the time ofparturi-
tion, although they developed symptoms
later. Therefore, it was considered that
the fetus is particularly vulnerable to
methylmercury neurotoxicity.
In a subsequent episode in Iraq, people
were exposed to methylmercury as a result
ofdistribution ofseed grain treated with a
methylmercury fungicide. Rural people used
the grain to make bread. The total number
ofofficial victims was 6530 including 459
deaths. Observed symptoms induded pares-
thesia, malaise, ataxia, constriction ofvisual
fields, and hearing impairment. Babies
exposed in utero to methylmercury were
investigated forphysical and mental develop-
ment. A scoring system ofexamination
results was adopted in the investigation.
Although individual scores exhibited vari-
ability, a dose-response relationship was
observed between effects, such as retardation
ofwalking and neurological signs, and
maternal hair mercury concentration. From
these analyses, an estimated lowest effect
level was determined. Delays in speech
development have also beenobserved follow-
ing developmental methylmercury exposure
in this population, although the possible
contributionofhearingdeficits is unknown.
In astudyof234 Cree children 12 to 30
months ofage in Canada, the mother's peak
hair level was used as the index ofexposure
(17). Assessment ofseveral neurological
measures, in addition to the Denverdevelop-
mental scale, revealed only abnormal musde
tone or reflexes and onlyin boys. Therewas
not a dear dose-dependent relationship.
In a population-based study in New
Zealand (18,19), mothers consumed fish
on a frequent basis. Assessment on the
Denver development scale revealed abnor-
mal or questionable results at a higher
frequency in 4-year-old children of
mothers with hair levels of >6 pg/g dur-
ing pregnancy compared to a matched
control group. When these children were 6
to 7 years old, an average maternal hair
concentration of 15 pg/g was associated
with a poorer performance on the Wechsler
Intelligence Scale for Children (WISC).
However, the number ofchildren tested in
this studywas small (60-70).
Methylmercury is also a potent neuro-
toxicant in animals. Emphasis has been
placed on characterization ofdevelopmen-
tal neurotoxicity, although toxicity in adult
animals has also been demonstrated. Spyker
et al. (20) demonstrated that mice exposed
to methylmercury in uteroshowed impaired
swimming ability. Their result first
confirmed fetal methylmercury poisoning in
an animal model, although the impairment
was less severe compared to fetal Minamata
cases and was subtle before the mice were
forced to swim. Subsequently, a large num-
ber ofanimal studies were performed using
various methods; thus, a much wider range
of effects has been examined in animal
studies compared to the human studies.
As was the case for lead, considerable
research on neurotoxicity produced by
methylmercuryhas been performed in mon-
keys, presumably in response to the episodes
ofhuman poisoning. Research in adult
monkeys replicated the constriction ofvisual
fields and other visual deficits observed in
adult humans as a result ofmethylmercury
exposure (21); these findings ofsensory sys-
tem deficits have been extended in develop-
mentally exposed monkeys in which visual,
auditory, and somatosensory deficits have
been observed (22). Early developmental
exposure at high doses also produces the
pattern ofcerebral palsy and severe visual
deficits including blindness (23,24)
observed inhumans.
Research in monkeys has also addressed
the issue of cognitive impairment as a
result ofdevelopmental methylmercury
exposure. In utero exposure resulted in
impairment ofvisual recognition memory
(25) and retarded object permanence
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performance (26) when monkeys were
tested during infancy. Interestingly, this
same cohort of monkeys demonstrated
facilitated performance on a delayed spatial
alternation task when tested as adults (27).
In utero plus postnatal exposure failed to
produce deficits on a discrimination rever-
sal task during both the infant and juvenile
periods (28), even in a monkey with clear
motor signs ofmethylmercury intoxication.
It may be that the monkey does not provide
a good model ofthe gross cognitive impair-
ment observed after high-dose develop-
mental exposure in humans.
Methylmercury also produces neurotoxi-
city in rodents, despite some differences in
the neuropathology and pharmacokinetics
between rodents and primates (including
humans). The pattern ofneuropathological
damage in the brain is different in rodents
than in species with deep sulci; specifically,
methylmercury produces preferential dam-
age to deep sulci such as calcarine fissure
(subserving visual function) in adult humans
(29), a pattern which is replicated in pri-
mates (30,31) but not in rodents. However,
the pattern ofdamage after developmental
exposure is more diffuse in all species (29).
There are also significant toxicokinetic dif-
ferences between species, including blood
and whole-body half-times, and brain:blood
ratios (32). The rat is anomalous in having a
veryhigh red blood cell:plasma ratio, which
undoubtedly contributes to the very low
brain:blood ratio of0.06, compared to a
blood:brain ratio of2 to 5 for monkeys and
humans (22). The most obvious effect of
methylmercury in adult rodents is motor
deficit (33-36); reports ofeffects on activity
are conflicting (37,38). In utero exposure at
high doses reliably produces deficits in
motor function. Very high doses may result
in a decrease in locomotor activity (16),
while lower doses often produce no effect
(39-41). Both positive and negative results
have been obtained on simple learning tests
(16,22). The sensory system damage that is
a hallmark ofmethylmercury toxicity in
humans may not be produced by moderate
exposure in rodents based on indirect
evidence such as auditory startle response
and visual discrimination performance,
although high-dose in utero exposure pro-
duces changes in visual evoked potentials
(22) or blindness (29). Direct assessment of
auditory thresholds revealed no deficits in
methylmercury-exposed rats (39).
PolychiorinatedBiphenyls
Polychlorinated biphenyls (PCBs) are afam-
ily ofchlorinated hydrocarbons containing
209 different isomers (congeners). Their
major use was as a dielectric in transformers
and capacitors, although they had other
industrial uses as well. They were in wide-
spread use from the 1930s until the 1970s;
although PCBs were banned in the United
States in the 1970s and subsequently else-
where, they are presently aworldwide pollu-
tion problem. Residues persist in air, soil,
water, and sediment and can be detected in
biological tissue in most residents ofindus-
trialized countries. The chemicals are stored
in fat and are not readily excreted except in
breast milk.
In 1968 a tragic epidemic occurred in
Japan as a result ofcontamination ofrice
oil with PCBs and small amounts ofother
contaminants. Infants born to mothers who
consumed the contaminated oil had dark
pigmentation ofthe skin, low birth weight,
early eruption of the teeth, and swollen
gums and eyelids (42). In another incident
in Japan, affected children had hypotonic
reflexes, were dull and apathetic, and had
low IQs (43). Adults ingesting high levels
of contaminated oil suffered chloracne,
numbness and weakness of limbs, and
decreased peripheral nerve conduction
velocities. However, the developing fetus
was much more sensitive than the mother.
Children born to mothers exposed to a
high, acute dose of PCBs in Taiwan have
been followed for at least 6 years (44).
These children exhibited delayed develop-
mental milestones, deficits in intellectual
functioning, and other behavioral prob-
lems. These effects were observed at expo-
sure levels that produced overt signs
including gum hypertrophy, deformed or
pigmented nails, chloracne, hyperpigmen-
tation, and hair loss.
An extensive prospective study involved
Michigan children born to women who
consumed fish from Lake Michigan
(45-50). Reduced birth weight and head
circumference were associated with con-
sumption of contaminated fish. Fish
consumption by the mothers was also asso-
ciated with lower scores on the Brazelton
neonatal development scale in the infants.
Decreased visual recognition memory in
this same set ofinfants at 7 months ofage
was associated with both maternal fish con-
sumption and cord serum PCB levels (47);
this task is reasonably predictive of IQ
measured at school age. There was no asso-
ciation with postnatal exposure through
nursing. Decreased weight and poorer
short-term memory at 4 years ofage was
also associated with cord but not concur-
rent PCB levels (48-49). These measures
were not associated with concurrent blood
levels ofPCBs, polybrominated biphenyls,
lead, or dichlorodiphenyltrichloroethane
(DDT). Hypoactivity was associated with
concurrent blood PCB levels (49).
A prospective cohort of breast-fed
infants was followed for 60 months in a
North Carolina study (51-54). Mothers
had no known excessive exposure to PCBs.
Higher in utero PCB exposure, as assessed
by maternal milk fat PCBs, was associated
with hypotonicity and hyporeflexia; there
was no association with birth weight or head
circumference (54). Higher transplacental
but not postnatal PCB exposure was associ-
atedwith lower scores on the Bayley Scaleof
Intelligence at 6 and 12 months ofage (51).
There was no association between either
prenatal or concurrent PCB levels and out-
come on intelligence tests at 3 to 5 years.
Numerous developmental studies
in both rodents and monkeys have demon-
strated neurotoxicity as a result of PCB
exposure. A recent review (55) summarized
changes in activity levels, impaired neuro-
logical development, and impairment on
simple learning tasks in rodents whose
dams were exposed to various commercial
PCB mixtures, often with dosage regimens
that did not produce increased mortality or
decreased weight in the pups. Dams were
apparently unaffected. A series ofstudies in
rhesus monkeys was performed at the
University ofWisconsin. Maternal expo-
sure toArodor 1016 at doses approximating
0.007 or 0.028 mg/kg/day (56,57) begin-
ning prior to breeding and continuing until
infants were weaned at 4 months of age
resulted in hyperpigmentation in infants in
both dose groups and decreased weight in
the high-dose group (57). Impairment on a
learning and memory task was also
observed in the high-dose group during
infancy. Further testing ofcognitive func-
tion when these monkeys were juveniles
revealed no impairment (56,57). In studies
with Aroclor 1248, female monkeys were
exposed to 0 or 1.0 ppm PCBs in the diet
3 days aweek, or 0.5 ppm in the feed daily
beginning prior to breeding and continu-
ing until offspring were weaned at 4
months of age. Additional groups of
females exposed to 2.5 ppm produced a
number of sets of offspring: concurrent
with exposure or in which exposure in the
mothers ceased 1.0, 1.5, or 3.0 years prior
to breeding. Concurrent exposure to
2.5 ppm resulted in reduced birth weight
(58) and deficits in discrimination reversal
learning (59). These monkeys were hyper-
active when young (59) and hypoactive at
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44 months ofage (60). Monkeys exposed
concurrently to 0.5 ppm were hyperactive
at 12 months ofage (61). The group born
to mothers 1.0 year after cessation of
exposure to 2.5 ppm showed facilitated
performance on a shape discrimination-
reversal task (56), which the authors inter-
preted as a deficit in the treated group's
ability to learn the irrelevance ofthe shape
cue on a previous task. The performance of
the 1.0 ppm group was not impaired on
this task. Monkeys born to mothers 1.5 or
3.0 years after cessation of exposure
to 2.5 ppm PCBs were impaired on a
spatial alternation task at 4 to 6 years of
age (57). The mothers did not exhibit
signs ofneurotoxicity.
There is excellent correspondence
between the effects ofdevelopmental PCB
exposure in the monkey and that observed
in humans, including learning deficits,
changes in activity, and hyperpigmenta-
tion. The rodent also provides a good
model for effects in humans, with changes
in activity levels and learning deficits
observed as a result ofperinatal exposure.
It is not possible to determine whether
behavioral processes underlying observed
deficits are the same in animal models
compared to humans because the issue has
not been addressed.
Predicted Ability of
Standard Neurotoxicity Tests
to Detect Neurotoxicity
There is a question central to the theme of
this review: Knowing what we know today,
ifanother agent that has effects similar to
those ofthese model neurotoxicants were
submitted to a governmental agency for
marketing, would its neurotoxic potential be
detected? Can we feel secure that the arsenal
ofmethodology available to the experimen-
tal behavioral toxicologist today would
detect these agents as neurotoxicants? How
well would these methodologies predict
effects observed in humans? Would the
methods generally required by regulatory
agencies detect these agents as neurotoxic,
or would their neurotoxic potential be
missed? One ofthe difficulties in attempt-
ing to answer these questions is that
different testing strategies are required by
different governments, different agencies
within the same government, or for differ-
ent classes of agents depending upon
chemical structure or intended use. In
some instances, observation ofadultanimals
would provide the only opportunity to
detect neurotoxicity. Under other protocols,
reproductive studies are required. For the
purposes ofthe present exercise, protocols
requiring acute exposure in adults, longer
term exposure (e.g., 28 days) in adults, or
reproductive/developmental exposure were
considered. It was assumed that rats or mice
would be the experimental model, and
effects reported in both species were consid-
ered. For each type ofprotocol, an attempt
was made to determine whether effects have
been observed on end points included in the
functional observation battery (FOB), motor
activity, simple tests oflearning/memory, or
schedule-controlled operant behavior
(SCOB). These tests have been recom-
mended by various agencies as appropriate
under various conditions. The results ofthis
analysis are presented in Table 1.
One conclusion that may be drawn
from this analysis is that all of the agents
would have been identified as neurotoxic at
some dosage level in some exposure proto-
col. It is probable that neither lead nor
PCBs would have been identified as neu-
rotoxicants following short-term adult
exposure, while methylmercury would be
identified on the basis of motor deficits.
On the other hand, lead, PCBs, and
methylmercury would have been identified
as developmental neurotoxicants at high
doses on the basis ofscreening procedures
such as the FOB, although the effects of
these agents on other measures at lower
doses is a little less clear.
Behavioral analysis in rats exposed
developmentally to lead has reliably
Table 1. Predicted ability of standard tests to detect neurotoxicity of model agents.
Lead Methylmercury PCBs Solvents
Adult acute
FOB No motor effect(62) No neurological signs(668-68) Noneb Yesc
Motor impairment(63)
(3 days injection)
Locomotor activity ? Yes(69) None Yes
Simple learning/SCOB None(98,63) No (67) None Yes
Adult longer-term (e.g., 28 days)
FOB No effect after 15 weeks(38) Landing foot splay, weakness, Noneb ?
irritability(36,66,68-70)
Locomotor activity No effect until 6 weeks(38) None, rat(38) None Yesc
Yes, mouse (69)
Simple learning/SCOB None(98,38) CAR, rat, effect after 9 weeks(38) None ?
No effectavoidance, rat (71)
Developmental (reproductive)
FOB High dose, paraplegia, Cerebral palsy, spasticity, Neurological signs, Yes/nod
tremors(64) seizures, at high doses(298,40,72) impaired incline screen,
spinning(538)
Locomotoractivity Both increase Negative(39-41) Increase ordecrease (53) ?
and decrease(64,65) Positive (based on 6 labs)(73)
Simple learning/SCOB Numerous effects(9a) Effect on water maze, Avoidance, water maze, ?
avoidance(298,73) learning, memory(538,74,75)
No effect on learning, memory(39,74) Fl (76)
No effect, RAM (77)
Abbreviations: FOB, functional observation battery; SCOB, shedule-controlled operant behavior; CAR, conditioned avoidance response; FIfixed interval; RAM, radial arm maze.
'Review article. bNo mention of neurotoxicity in numerous studies. CExpected at high doses as a result of narcotic effects. dExpected as a result of known effects. 'Expected
effect, depending on agent.
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revealed deficits in learning and perfor-
mance at blood lead levels that are environ-
mentally relevant (8,10,14). Such effects
were detected in some instances on com-
plex tasks using very sophisticated data
analysis. However, lead-induced changes
have also been detected using intermittent
schedules of reinforcement. Such behav-
ioral methodology is a standard part ofthe
arsenal of behavioral tests available to the
behavioral pharmacologist and toxicologist.
It must be pointed out that these are not
screening procedures, however; they
require automated equipment and opti-
mally a computer to control the experi-
ment and collect data on line. If simple
tests of learning that do not necessarily
require automated equipment are consid-
ered, lead-induced deficits were revealed in
general after prenatal exposure only, even
at high doses. At very high doses, prenatal
exposure resulted in overt signs oftoxicity
in the pups including nervous system
lesions and paralysis. It is clear, then, that
high-dose effects in rodents mimic those
observed following high-dose developmen-
tal exposure in humans. It is significant,
however, that the intraperitoneal route of
exposure in general resulted in negative
results (9). It was necessary for the expo-
sure route to be the same as that ofhuman
exposure, i.e., oral. It is also important to
point out that, while effects on such
screening tests as locomotor activity were
sometimes (but not always) positive, results
were inconsistent, with both increased and
decreased locomotion observed. It might
be tempting to conclude in such circum-
stances, if the agent in question were not
already known to be neurotoxic, that such
effects did not reflect neurotoxicity.
It is clear that perinatal exposure to
methylmercury at high doses produces overt
neurological effects that would be detected
on the FOB. Methylmercury generally pro-
duced decreased locomotor activity in pups
whose dams were exposed to high doses,
while more recent studies at lower doses
have been negative. The effects of
methylmercury on simple tests of learning
are equivocal, with both positive and nega-
tive results reported (22). Methylmercury
reliably increased auditory startle in a collab-
orative study ofsix laboratories, with incon-
sistent effect on a discrimination task (73).
No effects of developmental methyl-
mercury exposure were observed on a bat-
tery developed at the U.S. Environmental
Protection Agency (U.S. EPA). This bat-
tery included T-maze alternation, auditory
startle, and olfactory discrimination (39).
In a European collaborative study, there
were no effects on accuracy on visual dis-
crimination reversal and spatial delayed
alternation tasks, although changes in audi-
tory startle were observed (74). Changes in
latency to respond and failure to respond
were observed, which would not necessarily
be interpreted as cognitive deficits.
Developmental exposure to PCBs
produces neurotoxic effects in rodents with
good reliability. High doses result in
neurological signs and impaired motor
development, which would presumably be
detected on an FOB. PCB exposure also
produces changes in locomotor activity,
although both increased and decreased
activity have been observed. High doses
also result in impairment on simple learn-
ing tasks such as active avoidance and
water-maze performance. Effects have been
observed on SCOB (76) and delayed alter-
nation performance (77) but not on radial
arm-maze performance (77). It seems clear
that PCBs would have been identified as
neurotoxic to the developing organism
based on studies in rodents.
The ability ofadult exposure paradigms
to detect neurotoxicity in these three agents
is less clear. Industrial exposure to lead in
adult humans results in motor effects, as
well as in psychiatric and cognitive distur-
bances following long-term exposure. It is
generally recognized that the adult rodent is
extremely resistant to lead-induced neuro-
toxicity (62). Administration ofvery high
doses for a number ofdays may produce
hind-limb weakness while repeated expo-
sure to lower doses produced no effect on
various measures included in the FOB. A
15-week exposure to high doses resulted in
decreased body weight and motor activity,
with no effect on body temperature, grip
strength, negative geotaxis, startle, or condi-
tioned avoidance response (CAR) (38).
Effects became apparent 6 weeks after expo-
sure started, so they would not have been
detected in a 28-day study. Attempts to
demonstrate impaired learning as a result of
adult exposure have been largely negative
(9). Other effects such as nephrotoxicity are
apparent at doses lower than those needed
to produce overt neurological signs. It is
therefore unlikely that leadwould have been
regulated as a neurotoxicant on the basis of
tests in adult rodents.
Methylmercury reliably produces gross
neurological signs and changes in other
measures of the FOB following repeated
exposure in adult rodents; however, results
after a single administration ofmethylmer-
cury have been negative. Locomotor activity
has been found to be affected in one study
(69). There has been little research on the
effects ofmethylmercury on learning tasks
in the adult rodent, but effects that have
been observed may be attributed to sensory
or motor impairment (38).
For PCBs, little or no research has
specifically addressed the issue ofneurotox-
icity as a result of exposure in adult
animals. However, it is clear that other
organ systems are more sensitive to PCB
toxicity than the nervous system. The
effects of PCBs in adult rodents at high
doses include changes in body weight and
impairment ofliver, kidney, and immune
function. Perusal of dozens of papers
revealed no mention of overt neurotoxic
effects. It is also clear that reproductive and
developmental neurotoxicity are produced
at doses that do not result in any overt tox-
icity in the mothers. It seems reasonable to
assume, then, that if only adult exposure
were used to assess PCB toxicity, the
nervous system would not have been
identified as a target.
The recognition that solvents repre-
sented a hazard at levels that did not
produce narcosis arose from long-term
industrial exposure. Therefore animal
research focused on effects in adult ani-
mals. Screening tests would certainly detect
the fact that solvents produce narcosis, and
results oftests ofmotor activity or learning
would be confounded by this effect, partic-
ularly at high doses. Little research has
been performed on the effect of solvents
on development.
Congruence of
Exposure Levels at Which
Neurotoxicity Is Observed in
Humans and Animals
An additional issue worth addressing is the
correspondance between the dose levels at
which neurotoxicity has been observed in
animals and the estimated intakes that
produce neurotoxic effects in humans for
these model agents. The protection pro-
vided by the ways in which animal data are
used in the risk assessment process to pro-
tect human health may also be scrutinized.
For this exercise, the rules by which refer-
ence doses (RfDs) are derived by the U.S.
EPA will be used, since these or similar
procedures are currently used by other
agencies as well. The central question is
this: From the results ofthe FOB, locomo-
tor activity, and effects on simple learning
tests or performance on SCOB, would the
derived RfDs protect against neurotoxicity
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Table 2. Comparison of doses required to produce neurotoxicity in humans and rodents and calculated RfDs(mg/kg/day).
Human Rodent
Compounds Exposure NOAEL Rfd NOAEL Rfd
Lead Adult Occupational exposure ? 5.2 5.2 x10-2
Developmental 5x10-3a 5x104-1 x10-3 1(LOAEL)- >100 1iD3- >1
Methylmercury Adult 3 x10-3 3 x10 0.7-1.6 7 x10-3-1.6x10-2
Developmental 7x10D4-1.2x10-3 7x105-1.2x104 5x10-3- >2 5x10-5- >2x10-2
PCBs Adult ? No effect
Developmental 10-5 104 0.2-5 2x10-3-10-2
"Based on estimated 50th percentiles for intake from food by children 2 years of age. Data from Beloian(78).
in humans? The conclusions are summa-
rized in Table 2.
Lead produces neurotoxicity in adult
rodents after repeated but not acute expo-
sure, but only at doses that produce mor-
tality or significant weight loss. The lowest
observed adverse effect level (LOAEL) for
decreased motor activity was 7.5 mg/kg,
with a no observed adverse effect level
(NOAEL) of 5.2 mg/kg (38). In general,
learning has been found to be unaffected
by lead exposure in adult rodents (9). The
intake necessary to produce neurotoxic
effects in adult humans has not been
quantified. More information is available
on the effects ofdevelopmental exposure to
lead. The studies in which behavioral
effects were detected at the lowest dose in
rodents were performed by Cory-Slechta
and colleagues using a post-weaning expo-
sure paradigm (8). Neurotoxicity was
detected at a dose ofapproximately 1 mg/kg
(10), three orders ofmagnitude higher than
the average lead intake by children,
although assessment was not performed at
lower doses in the rat studies. In those stud-
ies, effects were demonstrated in perfor-
mance on schedules ofreinforcement and
complex learned behavior using sophisti-
cated methodology. If a factor of 1000 is
considered to be an appropriate safety fac-
tor-the procedure used for agents for
which there is a LOAEL but not a NOAEL
from animal data-the RfDs based on the
animal data are in good agreement with
estimates ofhuman intake. Most studies,
however, particularly earlier ones, detected
neurotoxicity at much higher doses; in
some studies doses over 100 mg/kg yielded
negative results (9). RfDs based on these
simple learning tests would yield RfDs
greater than 1 mg/kg, which clearly greatly
underestimates the toxicity oflead to the
developing organism.
For methylmercury, the present U.S.
EPA RfD of 0.3 pg/kg/day is based on
paresthesias in adults. In a 15-week study
in rats (38), 1.4 mg/kg/day produced
effects on motor function after 3 months
ofexposure while 0.7 mg/kg/day produced
no effect. A safety factor of100 would yield
an allowable intake of 7 pg/kg/day.
Landing foot splay in the mouse was
affected after exposure to 2.7 mg/kg/dayfor
less than 28 days, while 1.6 mg/kg/day pro-
duced impairment after more than 60 days
(36). An RfD based on a 28-day exposure
would be 16 pg/kg/day. RfDs generated
from these two studies are one to two
orders ofmagnitude above the RfD based
on adult human data. With respect to the
developmental effects of methylmercury
exposure, Stern (79) derived a reference
dose of0.07 pg/kg/day based on develop-
mental neurotoxicity in humans, while the
Agency for Toxic Substances and Disease
Registry has determined a minimum risk
level of0.12 pg/kg/day based on the same
data (80). It must be reiterated that the
developmental data at this point consist of
relatively crude end points, unlike the very
extensive body ofdata on subtle behavioral
deficits that exists for lead. Most rodent
studies reported NOAELs between 50 and
>2000 pg/kg/day depending on the study
and end point examined (22). Tests that
would typically be used in an assessment
battery yielded values at the high end of
this range. For example, in an interlabora-
tory study involving six laboratories (73),
effects were observed at 6 mg/kg adminis-
tered on gestation days (GD) 6 to 9 while
effects were minimal or absent at 2 mg/kg
on simple tests ofactivity and learning. In
another study in which rats were dosed
from GD 6 to 15, no effectwas observed at
1 or 2 mg/kg using a testing battery devel-
oped at the U.S. EPA, including several
tests oflearning and activity (39). RfDs
generated from these two studies would be
10-2 mg/kg/day or higher, two to three
orders ofmagnitude greater than the RfD
calculated from the human data. In con-
trast, a study in which rats were required to
perform on a differential reinforcement of
high rate (DRH) schedule, which required
the animal to emit a specific number of
responses within a specified time, detected
effects at a much lower level than other
studies (81). Adose of 10 pg/kg during GD
6 to 9 produced effects, with a NOAEL of
5 pig/kg. With a safety factor of 100, the
allowable intake would be 0.05 pg/kg/day,
which is in very good agreement with esti-
mates based on the human data. It is highly
unlikely that an allowable intake for
methylmercury in humans would have been
based on a single apparently anomalous
rodent study, however. The experimental
design of most ofthese studies in which
dams were dosed for only several days dur-
ing pregnancy also presents problems in
extrapolating the rodent data to humans.
While perinatal exposure to PCBs reli-
ably produces a variety ofbehavioral effects
in rodents, the doses at which these effects
have been identified are considerably higher
than those at which untoward effects appar-
ently occur in humans. In their review,
Tilson et al. (55) calculated RfDs based on
rodent, monkey, and human data. RfDs
from the human data were calculated to be
approximately 10-5 to 10-6 mg/kg/day
based on behavioral data, using a safety fac-
tor of 10 below the estimated NOAEL.
RfDs from the monkey data, based on
motor activity and impairment on learning
and memory tasks, were in the range of
10-5 mg/kg/day, which is in good agree-
ment with the human estimates. RfDs from
most measures ofdevelopmental toxicity
based on the rodent data were approxi-
mately 10-2 mg/kg/day; the most sensitive
indicator was motor activity, which yielded
an RfD of 10-3 mg/kg/day based on a
NOAEL of0.2 mg/kg/day and dividing by
a safety factor of 100. This is three orders of
magnitude higher than the estimates of
intake that would protect against develop-
mental neurotoxicity in humans. While the
assumptions used to calculate the human
RfDs may have resulted in an underestima-
tion ofthe dose required to produce effects,
it is doubtful that adjustments in the calcu-
lations would result in a change in the RfD
bythree orders ofmagnitude. Moreover, the
calculations based on monkey data, which
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are not subject to the same uncertainties in
intake estimates, are in close agreement with
the estimates based on the epidemiological
studies. It therefore appears that the rodent
data underestimate the intake that would
protect against neurotoxicity in humans by
about three orders ofmagnitude, based on
currently accepted practices of estimating
human risk from animal data.
An alternative strategy would be to base
allowable intakes on body burden rather
than dose. This would have the advantage of
at least partiallycircumventing differences in
toxicokinetics between humans and animal
models. The most relevant comparison
would be levels in target organ tissues, i.e.,
the nervous system. For example, in their
review Burbacher et al. (29) point out that
there is good congruence between signs of
methylmercury toxicity between small
mammals, primates, and humans based on
brain mercury levels. Ofcourse, such com-
parative data are not available for most
agents. A readily accessible compartment is
the blood compartment. For lead, clear
effects in rats have been observed in experi-
ments by Cory-Slechta and colleagues at
blood lead levels ofapproximately 20 pg/dl
(14); lower levels have not been studied. A
recent meta-analysis ofthe epidemiological
literature showed no evidence of a thresh-
old for cognitive deficits produced by lead
down to blood lead concentrations of
1 lig/dl (7). Ifone safety factor of 10 were
eliminated for interspecies extrapolation
because a measure of body burden was
being compared directly between rats and
humans, the allowable blood lead concen-
tration based on these rodent data would
be 0.2 pg/dl, which is in good agreement
with the epidemiological conclusions.
Blood levels associated with neurotoxicity
are unknown for either methylmercury or
PCBs in the rodent. However, methyl-
mercury blood levels in the rat would
undoubtedly be extremely misleading,
given the huge difference in blood:brain
ratios between rat and human. In
addition, most current government regu-
latory protocols do not require measures
of body burden; therefore, such data
would be unavailable from animal studies.
Moreover, ifthe agent being tested were a
new chemical to which humans had not
been exposed, relevant data from humans
and particularly from children would also
be lacking. The strategy of basing allow-
able intakes in humans on comparison of
body burden between human and animal
models is therefore not at all practical for
new agents.
Conclusions
There are a number ofconclusions that may
be drawn from the exploration ofeffects in
these model compounds. First, it is clear
that the degree to which the effects of
assessment ofspecific functions in animals
predict effects in humans depends on both
the agent and the developmental period at
which exposure occurs. Developmental lead
exposure in humans is characterized by
deficits in IQand other problems ofcogni-
tive functioning. Cognitive deficits have
been reliably demonstrated in animal mod-
els including rodents and primates. In fact,
the experimental and epidemiological liter-
atures show remarkable congruence with
regard to the behavioral processes underly-
ing these deficits. The ability of effects in
adult animals to predict effects produced
by lead in humans is disappointing. It is
doubtful that the peripheral neuropathy
and changes in cognitive function pro-
duced by occupational exposure would be
predicted on the basis of rodent studies.
While chronic lead exposure may produce
changes in locomotor activity in rodents,
studies ofneurological function and learn-
ing have been almost universally negative.
Methylmercury produces severe neurologi-
cal impairment in humans as a result of
adult exposure; these effects are replicable
in animal models only after repeated expo-
sure. One ofthe hallmarks ofmethylmer-
cury poisoning in adults is constriction of
visual fields and other visual effects. This
probablywould not have been predicted by
rodent tests because of differences in the
pattern of pathological damage between
human and rodent brain and because of
important differences in the visual systems
between humans and rodents. Such effects
have been demonstrated in monkeys
exposed as adults, however. Developmental
exposure to methylmercury in humans
results in neurological impairment at high
levels ofexposure and developmental delay
and possibly cognitive impairment at lower
exposure levels. Developmental exposure in
animals clearly replicates the neurological
dysfunction observed in human infants.
On the other hand, results of tests ofcog-
nitive function in both rodents and mon-
keys is conflicting (22). Developmental
PCB exposure produces behavioral delays
or cognitive deficits in children. In good
agreement with these findings, deficits on
tests of learning and changes in activity
have been demonstrated as a result ofPCB
exposure in both rodents and monkeys.
Adult monkeys chronically exposed to
PCBs develop the classic signs of PCB
toxicity in humans, including chloracne,
hair loss, and swelling of the eyelids
(82,83); however, whether PCB exposure
in adult monkeys also produces the pares-
thesias and weakness reported in humans
has not been addressed. Neurotoxicity has
not been reported in adult rodents as a
result ofPCB exposure.
The ability ofanimal studies to predict
intake levels at which human health would
be protected is less encouraging. It is clear
from comparison ofthe human and rodent
data that results from rodent studies often
vastly underestimated intakes at which
neurotoxicity was observed in humans. For
PCBs, the difference in the estimated
acceptable intake between human and
rodent developmental data is 3 to 4 orders
ofmagnitude, while for methylmercury the
difference is two orders of magnitude or
greater for most studies. For lead, deficits
were revealed on activity and simple learn-
ing tests at doses that would also result in
allowable intakes much higher than those
at which cognitive impairment has been
demonstrated in children. However, data
from one laboratory using sophisticated
analyses ofbehavior on operant schedules
of reinforcement detected impairment at
levels that would result in derivation ofan
RfD that would clearly indicate that
human health was not protected at intake
levels of many children in industrial soci-
eties. One conclusion that may be drawn
from this analysis is that current methods
ofcalculating acceptable intakes based on
animal data, exemplified for the sake of
discussion by current practices in the
United States, are insufficient to protect
the human population against behavioral
toxicity. It may be argued that agents such
as lead, methylmercury, and PCBs repre-
sent worst case scenarios because these
agents have been released into the environ-
ment in huge quantities, are not degraded
environmentally, accumulate in the food
chain, and/or have very long biological
half-lives in humans. Therefore the degree
to which the lessons from these potent
neurotoxicants may be extrapolated to
other agents needs to be interpreted with
some caution. However, the clarification of
these issues for new agents would require
extensive biological and environmental
testing. It seems unlikely that such issues
would be satisfactorily resolved for pro-
posed new chemicals before their approval
and use. (For example, it was argued that
lead would not accumulate in the environ-
ment when industry proposed adding lead
to gasoline.)
Environmental Health Perspectives - Vol 104, Supplement 2 * April 1996 212LESSONS FROM MODEL COMPOUNDS
It might also be suggested that sophis-
ticated behavioral testing, including devel-
opmental testing, be required for all
chemicals suspected ofproducing neuro-
toxicity. A tiered approach has been sug-
gested by a number of national and
international agencies whereby detection of
neurotoxicity at high doses would trigger
assessment at lower doses using more
sophisticated methodology. While such a
strategy would undoubtedly aid in the
characterization ofeffects as well as result
in detection of neurotoxicity at lower
doses, it is unlikely that this strategy
would provide sufficient protection in all
cases. For example, numerous reproduc-
tive studies using reasonable end points
generated NOAELs as much as five orders
of magnitude above those estimated from
human data (Table 2). It is doubtful that
any test done in rodents, no matter how
sophisticated, would lower the dose
at which impairment was detected by such
an amount.
In conclusion, neurotoxicity would have
been detected for all ofthese model agents
only if both developmental and adult
assessments had been performed. In addi-
tion, doses atwhich effects were observed in
rodents were often several orders ofmagni-
tude higher than those atwhich effects were
actually observed in humans. Whether
these agents would have been approved for
use would ultimately depend on decisions
made subsequent to the detection of the
fact that these agents were neurotoxic.
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